Matches in SemOpenAlex for { <https://semopenalex.org/work/W2586751473> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2586751473 endingPage "AB387" @default.
- W2586751473 startingPage "AB387" @default.
- W2586751473 abstract "Much of the focus of current research is on study outcomes, but what happens once patients complete study protocols? This quality improvement project sought to gain insight into life after three types of peanut immunotherapy- oral (OIT), oral+ omalizumab (O+OIT) and epicutaneous (EPIT). This project surveyed 33 participants who participated in 3 different clinical trials for peanut. Questionnaires were distributed about study participation, desensitization method and impact on daily life. All participants responded and were happy they participated. 29 subjects introduced peanut into their diet. However, 16 reported dosing interfered with daily life. Quantity of peanut consumption varied. 89% of O+OIT consumed at least 300 mg compared to 56% with OIT and 53% with EPIT. 11% of O+OIT patients are completely avoiding compared to EPIT (20%) and OIT (22%). Dosing frequency varied from once per month to daily. Only six participants liked the taste and were from the EPIT cohort. One patient in each OIT and O+OIT groups was interested in eating more compared to nine (82%) EPIT. Since completion, four experienced allergic reactions requiring epinephrine due to dosing (O+OIT: 3; EPIT: 1). Two participants in both the OIT and O+OIT currently complain of increased gastrointestinal symptoms. Overall participants had success, yet incorporating continued ingestion proves challenging and optimum dosing still needs to be determined. The O+OIT group reached the highest doses, but had the greatest frequency of reactions. The EPIT group appears to like peanut suggesting a possible different mechanism of immunotherapy." @default.
- W2586751473 created "2017-02-17" @default.
- W2586751473 creator A5004503452 @default.
- W2586751473 creator A5007083526 @default.
- W2586751473 creator A5020477500 @default.
- W2586751473 creator A5047011247 @default.
- W2586751473 creator A5052232107 @default.
- W2586751473 creator A5058190903 @default.
- W2586751473 creator A5059411807 @default.
- W2586751473 creator A5071065053 @default.
- W2586751473 creator A5071700754 @default.
- W2586751473 date "2017-02-01" @default.
- W2586751473 modified "2023-09-27" @default.
- W2586751473 title "Life after Peanut Immunotherapy" @default.
- W2586751473 doi "https://doi.org/10.1016/j.jaci.2016.12.931" @default.
- W2586751473 hasPublicationYear "2017" @default.
- W2586751473 type Work @default.
- W2586751473 sameAs 2586751473 @default.
- W2586751473 citedByCount "3" @default.
- W2586751473 countsByYear W25867514732018 @default.
- W2586751473 countsByYear W25867514732020 @default.
- W2586751473 countsByYear W25867514732022 @default.
- W2586751473 crossrefType "journal-article" @default.
- W2586751473 hasAuthorship W2586751473A5004503452 @default.
- W2586751473 hasAuthorship W2586751473A5007083526 @default.
- W2586751473 hasAuthorship W2586751473A5020477500 @default.
- W2586751473 hasAuthorship W2586751473A5047011247 @default.
- W2586751473 hasAuthorship W2586751473A5052232107 @default.
- W2586751473 hasAuthorship W2586751473A5058190903 @default.
- W2586751473 hasAuthorship W2586751473A5059411807 @default.
- W2586751473 hasAuthorship W2586751473A5071065053 @default.
- W2586751473 hasAuthorship W2586751473A5071700754 @default.
- W2586751473 hasBestOaLocation W25867514731 @default.
- W2586751473 hasConcept C126322002 @default.
- W2586751473 hasConcept C141105273 @default.
- W2586751473 hasConcept C159110408 @default.
- W2586751473 hasConcept C159654299 @default.
- W2586751473 hasConcept C170493617 @default.
- W2586751473 hasConcept C203014093 @default.
- W2586751473 hasConcept C2777288759 @default.
- W2586751473 hasConcept C2778564945 @default.
- W2586751473 hasConcept C2779779143 @default.
- W2586751473 hasConcept C2779951463 @default.
- W2586751473 hasConcept C3018710434 @default.
- W2586751473 hasConcept C535046627 @default.
- W2586751473 hasConcept C71924100 @default.
- W2586751473 hasConceptScore W2586751473C126322002 @default.
- W2586751473 hasConceptScore W2586751473C141105273 @default.
- W2586751473 hasConceptScore W2586751473C159110408 @default.
- W2586751473 hasConceptScore W2586751473C159654299 @default.
- W2586751473 hasConceptScore W2586751473C170493617 @default.
- W2586751473 hasConceptScore W2586751473C203014093 @default.
- W2586751473 hasConceptScore W2586751473C2777288759 @default.
- W2586751473 hasConceptScore W2586751473C2778564945 @default.
- W2586751473 hasConceptScore W2586751473C2779779143 @default.
- W2586751473 hasConceptScore W2586751473C2779951463 @default.
- W2586751473 hasConceptScore W2586751473C3018710434 @default.
- W2586751473 hasConceptScore W2586751473C535046627 @default.
- W2586751473 hasConceptScore W2586751473C71924100 @default.
- W2586751473 hasIssue "2" @default.
- W2586751473 hasLocation W25867514731 @default.
- W2586751473 hasOpenAccess W2586751473 @default.
- W2586751473 hasPrimaryLocation W25867514731 @default.
- W2586751473 hasRelatedWork W1527627580 @default.
- W2586751473 hasRelatedWork W2035760867 @default.
- W2586751473 hasRelatedWork W2111330076 @default.
- W2586751473 hasRelatedWork W2485922056 @default.
- W2586751473 hasRelatedWork W2562509397 @default.
- W2586751473 hasRelatedWork W286777929 @default.
- W2586751473 hasRelatedWork W2914728183 @default.
- W2586751473 hasRelatedWork W3088273840 @default.
- W2586751473 hasRelatedWork W3088952571 @default.
- W2586751473 hasRelatedWork W2229798320 @default.
- W2586751473 hasVolume "139" @default.
- W2586751473 isParatext "false" @default.
- W2586751473 isRetracted "false" @default.
- W2586751473 magId "2586751473" @default.
- W2586751473 workType "article" @default.